Long-term survival in patients with advanced immunodeficiency

AIDS

Volumn 11, Issue 2, 1997, Pages 209-216

  Chêne, Geneviève ^a,c   Easterbrook, Philippa J ^b   Juszczak, Ed ^a   Yu, Ly Mee ^b   Pocock, Stuart J ^a   Gazzard, Brian G ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c INSERM   (France)

Author keywords

CD4 cell count; Disease progression; Epidemiology; Survival

Indexed keywords

CD4 ANTIGEN; HEMOGLOBIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BIOSTATISTICS; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HUMANS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS;

EID: 0031036780     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199702000-00012     Document Type: Article

References (21)

1. Easterbrook PJ, Emami J, Gazzard B, et al.: Progressive CD4 cell decline and death in zidovudine-trealed patients. J Acquir Immune Defic Syndr 1993, 6:927-929.
2. Yarchoan R, Venzon DJ, Pluda JM, et al.: CD4 count and the risk of death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 1991, 115:185-189.
3. Apolonio EG, Hoover DR, He Y, et al.: Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/ml. J Infect Dis 1995, 171:829-836.
4. Easterbrook PJ, Emami J, Gazzard B: Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients. AIDS 1993, 7:959-967.
5. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1S):1S-15S.
6. Kaplan EL, Meier P: Non parametric estimation from incomplete samples. J Am Stat Assoc 1958, 53:457-481.
7. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
8. Cox DR: Regression models and life tables. J R Stat Soc [B] 1972, 34:187-200.
9. Collett D: Modelling Survival Data in Medical Research. London: Chapman & Hall; 1994.
10. Colford JM, Ngo L, Tager I: Factors associated with survival in HIV-infected patients with very low CD4 counts. Am J Epidemiol 1994, 139:206-218.
11. Keel JPM, Krol A, Kool M, et al.: Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 106/I but free of AIDS-defining clinical disease. AIDS 1994, 8:1577-1583.
12. Kotter DP, Tiernay M, Wang J, et al.: Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989, 50:444-447.
13. Burcham J, Marmor M, Dubin N, et al.: CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991, 5:365-372.
14. 6/I. AIDS 1995, 9:145-152.
15. Saah AJ, Hoover DR, He Y, et al.: Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1994, 7:287-295.
16. Graf W, Glimelius B, Pahlman L, et al.: Determinants of prognosis in advanced colorectal cancer. Eur J Cancer 1991, 27:1119-23.
17. Thrasher JB, Frazier HA, Robertson JE, et al.: Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994, 73:1708-1715.
18. Davis BR, Zauli G: Effect of human immunodeficiency virus infection in haematopoeisis. Bailliere Clin Haematol 1995, 8: 113-130.
19. Henry DH, Beall GN, Benson CA, et al.: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Infern Med 1992, 117:739-748.
20. Hoover DR, Graham NMH, Chen B, et al.: Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr 1992, 5:794-802.
21. Wyatt JC, Altman DG: Prognostic models: clinically useful or quickly forgotten? BMJ 1995, 311:1539-1540.